Topic
1 story, newest first.
Confidential deals struck by the Trump administration with pharmaceutical companies Pfizer and Eli Lilly included provisions that encouraged higher drug prices overseas and offered protection from tariffs. Documents obtained through Freedom of Information Act lawsuits revealed these terms, alongside broad confidentiality pledges from the Health and Human Services Department.
